Pattern Computer’s Pattern Discovery Engine will be used to analyse the scans to identify signatures indicative of cancer. Credit: Pormezz / Shutterstock.

Pattern Computer and the Medical College of Wisconsin (MCW) in the US have initiated a pilot study to evaluate the ProSpectral device for the detection of head, neck and lung cancers through saliva analysis.

The new study will utilise Pattern’s ProSpectral device to scan saliva samples from patients at risk or already diagnosed with these cancers.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

This multi-disease hyperspectral diagnostic tool will be employed at two speciality clinics within the Froedtert & MCW Cancer Network.

Pattern Computer’s AI-powered Pattern Discovery Engine will be used to analyse the scans to identify signatures indicative of cancer.

This research could significantly enhance early detection and diagnostic processes for cancer, particularly for high-risk groups.

See Also:

The ProSpectral platform is a portable, reagent-free bench-top hyperspectral instrument designed to be used with clinical samples.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

It aims to detect multiple diseases and, when combined with the Pattern Discovery Engine, can create predictive disease models with accuracy and speed.

The platform’s AI and machine learning algorithms can interpret complex data patterns in seconds.

Pattern chair and CEO Mark Anderson said “Pattern is making significant advances in transforming healthcare and is driving innovation in the field of oncology.

“As we work towards transforming cancer treatment paradigms, we are looking to partner with firms to bring our combination cancer drug discoveries and diagnostic advances against the world’s top five cancers into clinical trials.”

Leading the study is MCW Cancer Center Clinical Research associate director Razelle Kurzrock, who is supported by Dr Hui Zi Chen and Dr Ann Maguire.

Dr Maguire oversees the Hereditary Cancer Risk Clinic while Dr Chen will spearhead the study at the Lung Cancer Clinic.